Canbiola, Inc. Uplists to OTCQB Venture Market
November 15 2018 - 9:45AM
InvestorsHub NewsWire
HICKSVILLE, NY -- November 15, 2018 -- InvestorsHub
NewsWire -- Canbiola, Inc. (OTCQB: CANB), is pleased
to announce the Company has been approved for up-listing its common
shares for trading on the OTCQB Venture Market, a US trading
platform that is operated by the OTC Markets Group in New
York. The Company will trade on the OTCQB under symbol
"CANB". Canbiola is a manufacturer of proprietary CBD
non-psychoactive cannabinoid products extracted from the hemp plant
focused on the commercial development of hemp and CBD-based
products for both the medical and consumer market. Its
product line includes hemp oil drops (of various concentrations),
muscle and joint salves, and manufacturing of its new CBD CryoGel
pain relief product.
The OTCQB is the premier marketplace for entrepreneurial and
development stage US and international companies that are committed
to providing a high-quality trading and information experience for
their US investors. To be eligible, companies must be current in
their financial reporting, pass a minimum bid price test, and
undergo an annual company verification and management certification
process. The OTCQB quality standards provide a strong baseline of
transparency, as well as the technology and regulation to improve
the information and trading experience for investors. The ability
to have the Company's shares electronically transferred between
brokerages in the US is significantly more convenient and reduces
the costs incurred in trading shares. When shares are able to
trade electronically, existing investors benefit from greater
liquidity and execution speeds, while opening the door to new
investors that may have been previously been restricted from the
Company's shares.
According to Canbiola’s CEO Marco Alfonsi, "Listing on the OTCQB is
part of a long-term strategy to introduce the Company to a broader
audience and the timing of this listing complements the recent
progress we have made with the release of several new products plus
executing the agreement to acquire its manufacturing facility as a
wholly owned subsidiary thereby directly controlling its own
production.” Mr. Alfonsi added, "We expect our presence on the
OTCQB to further enhance trading liquidity and provide additional
exposure to US and institutional investors who are looking to align
with progressive companies like ours which are focused on
non-opioid-based all natural and organic compound products that
contain 99.9% pure CBD."
Alfonsi concluded, “This is a very exciting time in the world of
hemp and CBD and we are passionate about the potential to change
people’s lives with our CBD products.”
About Canbiola, Inc.:
Canbiola, Inc. is a public company trading under symbol
CANB.
Canbiola, Inc. is a US Company embarking in the sale of a
variety of Cannabidiol (CBD) based products. Canbiola has developed
its own line of proprietary products as well as seeking synergistic
value through acquisitions in the CBD and the medical cannabis
industry. Cannabis is currently federally illegal and has legalized
for medical purposes in some form in a limited number of states,
but pure CBD products are legal in all 50 states. The company has
already launched several products found
at www.canbiola.com.
CONTACT INFORMATION:
Canbiola Investor Relations
Email: IR@canbiola.com
Phone: (516) 595-9544
Website: http://www.canbiola.com
Follow us on Twitter and Facebook
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Aug 2024 to Sep 2024
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Sep 2023 to Sep 2024